Next-Generation Trial Designs: Adaptive, Platform, and Basket...

agregó una foto Other

2025-08-13 12:14:53 - Translate

Next-Generation Trial Designs: Adaptive, Platform, and Basket Studies in U.S. CGT Development

The U.S. cell and gene therapy clinical trials market, valued at USD 5.36 billion in 2024, is anticipated to expand at a CAGR of 15.3% from 2025 to 2034, with growth increasingly driven by segment-wise performance across therapy types, disease applications, and technological platforms. Unlike traditional pharmaceutical trials, CGT studies are characterized by high complexity, small patient...

0 Commentarios 0 Acciones 835 Views 0 Vista previa